Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Net Margin (2016 - 2025)

Historic Net Margin for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to 26.3%.

  • Iradimed's Net Margin fell 12500.0% to 26.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.45%, marking a year-over-year increase of 13200.0%. This contributed to the annual value of 25.31% for FY2024, which is 12500.0% up from last year.
  • Iradimed's Net Margin amounted to 26.3% in Q3 2025, which was down 12500.0% from 28.29% recorded in Q2 2025.
  • In the past 5 years, Iradimed's Net Margin registered a high of 32.79% during Q4 2021, and its lowest value of 14.98% during Q2 2021.
  • In the last 5 years, Iradimed's Net Margin had a median value of 24.72% in 2022 and averaged 24.15%.
  • As far as peak fluctuations go, Iradimed's Net Margin surged by 460700bps in 2021, and later plummeted by -80700bps in 2022.
  • Over the past 5 years, Iradimed's Net Margin (Quarter) stood at 32.79% in 2021, then decreased by -25bps to 24.72% in 2022, then fell by -28bps to 17.86% in 2023, then increased by 28bps to 22.95% in 2024, then grew by 15bps to 26.3% in 2025.
  • Its last three reported values are 26.3% in Q3 2025, 28.29% for Q2 2025, and 24.02% during Q1 2025.